Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Recent advances in androgen receptor action.

Lee HJ, Chang C.

Cell Mol Life Sci. 2003 Aug;60(8):1613-22. Review.

PMID:
14504652
2.

Molecular basis of androgen insensitivity.

Brinkmann AO.

Mol Cell Endocrinol. 2001 Jun 20;179(1-2):105-9. Review.

PMID:
11420135
3.

[The androgen receptor: molecular pathology].

Sultan Ch, Gobinet J, Terouanne B, Paris F, Belon Ch, Jalaguier S, Georget V, Poujol N, Auzou G, Lumbroso S.

J Soc Biol. 2002;196(3):223-40. Review. French.

PMID:
12465595
4.

Androgen receptor corepressors: an overview.

Wang L, Hsu CL, Chang C.

Prostate. 2005 May 1;63(2):117-30. Review.

PMID:
15486994
5.

Molecular cell biology of androgen receptor signalling.

Bennett NC, Gardiner RA, Hooper JD, Johnson DW, Gobe GC.

Int J Biochem Cell Biol. 2010 Jun;42(6):813-27. doi: 10.1016/j.biocel.2009.11.013. Epub 2009 Nov 30. Review.

PMID:
19931639
6.

Androgen receptor: an overview.

Chang C, Saltzman A, Yeh S, Young W, Keller E, Lee HJ, Wang C, Mizokami A.

Crit Rev Eukaryot Gene Expr. 1995;5(2):97-125. Review.

PMID:
8845584
7.

Physiology and pathophysiology of androgen action.

Hiort O, Holterhus PM, Nitsche EM.

Baillieres Clin Endocrinol Metab. 1998 Apr;12(1):115-32. Review.

PMID:
9890064
8.

Androgen-selective gene regulation in the prostate.

Haendler B.

Biomed Pharmacother. 2002 Mar;56(2):78-83. Review.

PMID:
12000138
9.

Molecular mechanisms of androgen action--a historical perspective.

Brinkmann AO.

Methods Mol Biol. 2011;776:3-24. doi: 10.1007/978-1-61779-243-4_1. Review.

PMID:
21796517
10.

Molecular regulation of androgen action in prostate cancer.

Dehm SM, Tindall DJ.

J Cell Biochem. 2006 Oct 1;99(2):333-44. Review.

PMID:
16518832
11.

[Androgen--biosynthesis, receptor and action].

Shiina H, Igawa M.

Nihon Rinsho. 1997 Nov;55(11):2860-4. Review. Japanese.

PMID:
9396277
12.

Clinical and molecular aspects of androgen receptor defects.

Wieacker PF, Knoke I, Jakubiczka S.

Exp Clin Endocrinol Diabetes. 1998;106(6):446-53. Review.

PMID:
10079022
13.

Androgen action.

Roy AK, Chatterjee B.

Crit Rev Eukaryot Gene Expr. 1995;5(2):157-76. Review.

PMID:
8845582
14.

Androgen receptor action in hormone-dependent and recurrent prostate cancer.

Agoulnik IU, Weigel NL.

J Cell Biochem. 2006 Oct 1;99(2):362-72. Review.

PMID:
16619264
15.

Androgen receptor mutations and androgen insensitivity.

McPhaul MJ.

Mol Cell Endocrinol. 2002 Dec 30;198(1-2):61-7. Review.

PMID:
12573815
16.

Androgen action.

Werner R, Holterhus PM.

Endocr Dev. 2014;27:28-40. doi: 10.1159/000363610. Epub 2014 Sep 9. Review.

PMID:
25247642
17.

Molecular action of androgen in the normal and neoplastic prostate.

Kokontis JM, Liao S.

Vitam Horm. 1999;55:219-307. Review. No abstract available.

PMID:
9949683
18.

Degradation and beyond: control of androgen receptor activity by the proteasome system.

Jaworski T.

Cell Mol Biol Lett. 2006;11(1):109-31. Review.

PMID:
16847754
19.

Androgen receptor: structural domains and functional dynamics after ligand-receptor interaction.

Roy AK, Tyagi RK, Song CS, Lavrovsky Y, Ahn SC, Oh TS, Chatterjee B.

Ann N Y Acad Sci. 2001 Dec;949:44-57. Review.

PMID:
11795379
20.

Regulation of androgen receptor levels: implications for prostate cancer progression and therapy.

Burnstein KL.

J Cell Biochem. 2005 Jul 1;95(4):657-69. Review.

PMID:
15861399

Supplemental Content

Support Center